Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential
Biomolecules · 27.05.2025 · 15 (6) · 777
DOI: 10.3390/biom15060777 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 27.05.2025. Verfasst von Nitika Patwa und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, DAV College, Ambala 133001, Haryana, India. Hauptthemen laut MEDLINE: Cymenes, Gastrointestinal Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: funder name.
Abstract (Originalsprache)
Gastrointestinal (GI) cancers, including esophageal, gastric, pancreatic, liver, and colorectal malignancies, represent a major global health burden due to their high incidence, aggressive nature, and limited treatment outcomes. This review explores the therapeutic potential of carvacrol, a naturally occurring monoterpenoid phenol predominantly found in oregano and other aromatic plants. Carvacrol has demonstrated strong anticancer properties by modulating multiple molecular pathways governing apoptosis, inflammation, angiogenesis, and metastasis. Preclinical studies have revealed its ability to selectively target cancer cells while sparing healthy tissue. Advances in nanotechnology have further enhanced its pharmacological profile by improving solubility, stability, and tumor-targeted delivery. Additionally, carvacrol shows synergistic effects when used in combination with conventional chemotherapeutics. While the evidence is promising, clinical studies are needed to validate its translational potential. This review aims to consolidate current findings and encourage further investigation into carvacrol’s application as an adjunct or alternative therapeutic agent in GI cancer management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, DAV College, Ambala 133001, Haryana, India.
- Section of Microbiology , Central Ayurveda Research Institute, Jhansi 284003, Uttar Pradesh, India.
- Department of Biotechnology, Ambala College of Engineering and Applied Research, Ambala 133001, Haryana, India.
- Department of Zoology, DAV College (Lahore), Ambala 133001, Haryana, India.
- Department of Biotechnology, Graphic Era (Deemed to Be University), Dehradun 248001, Uttarakhand, India.
- Department of Nursing, College of Nursing and Health Sciences, Jazan University, Jazan 45142, Saudi Arabia.
ORCID-Profile: Gagandeep Singh, Shafiul Haque, Vikas Yadav, Shakti Ranjan Satapathy, Hardeep Singh Tuli
Förderung
- funder name
Zitieren
APA
Patwa, N., Singh, G., Sharma, V., Chaudhary, P., Sharma, B., Haque, S., Yadav, V., Satapathy, S. R., & Tuli, H. S. (2025). Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential. Biomolecules, 15(6), 777. https://doi.org/10.3390/biom15060777
Vancouver
Patwa N, Singh G, Sharma V, Chaudhary P, Sharma B, Haque S, et al. Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential. Biomolecules. 2025;15(6):777. doi:10.3390/biom15060777
BibTeX
@article{Patwa2025,
author = {Patwa, Nitika and Singh, Gagandeep and Sharma, Vikas and Chaudhary, Priyanka and Sharma, Bunty and Haque, Shafiul and Yadav, Vikas and Satapathy, Shakti Ranjan and Tuli, Hardeep Singh},
title = {Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {6},
pages = {777},
doi = {10.3390/biom15060777}
}
EUVIMED